ANTITUMOR ACTIVITY OF BACTERIOPHAGES IN MURINE EXPERIMENTAL CANCER MODELS CAUSED POSSIBLY BY INHIBITION OF β3 INTEGRIN SIGNALING PATHWAY

被引:0
|
作者
Dabrowska, K. [1 ]
Opolski, A. [1 ]
Wietrzyk, J. [1 ]
Switala-Jelen, K. [1 ]
Boratynski, J. [1 ]
Nasulewicz, A. [1 ]
Lipinska, L. [1 ]
Chybicka, A. [2 ]
Kujawa, M. [3 ]
Zabel, M. [4 ]
Dolinska-Krajewska, B. [4 ]
Piasecki, E. [1 ]
Weber-Dabrowska, B. [1 ]
Rybka, J. [1 ]
Salwa, J. [1 ]
Wojdat, E. [1 ]
Nowaczyk, M. [5 ]
Gorski, A. [1 ,5 ]
机构
[1] Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland
[2] Med Univ Wroclaw, Dept Paediat Haematol & Oncol, Wroclaw, Poland
[3] Med Univ Warsaw, Ctr Biostruct, Warsaw, Poland
[4] Med Univ Wroclaw, Dept Histol & Embryol, Wroclaw, Poland
[5] Med Univ Warsaw, Inst Transplantol, PL-02006 Warsaw, Poland
关键词
phage T4; melanoma; antimetastatic activity; beta; 3-integrins;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacteriophages (phages) as bacterial viruses are generally believed to have no intrinsic tropism for mammalian cells. In this study the interactions between phages and various eukaryotic cells were investigated. Binding of phages to the membranes of cancer and normal blood cells was observed. Moreover, it was shown that the wild-type phage T4 (wtT4) and its substrain HAP1 with enhanced affinity for melanoma cells inhibit markedly and significantly experimental lung metastasis of murine B16 melanoma cells by 47% and 80%, respectively. A possible molecular mechanism of these effects, namely a specific interaction between the LysGly-Asp motif of the phage protein 24 and beta 3-integrin receptors on target cells is proposed. It was also shown that anti-beta 3 antibodies and synthetic peptides mimicking natural beta 3 ligands inhibit the phage binding to cancer cells. This is in line with the well-described beta 3 integrin-dependent mechanism of tumor metastasis. It is concluded that the blocking of beta 3 integrins by phage preparations results in a significant decrease in tumor invasiveness.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 50 条
  • [31] Combined Pharmacologic Inhibition of MEK-ERK and PI3K/mTOR Signaling in Glioblastoma Models Enhances Therapeutic Antitumor Activity
    Schreck, Karisa
    Allen, Amy
    Wang, Jiawen
    Pratilas, Christine
    NEUROLOGY, 2019, 92 (15)
  • [32] Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
    Ye, Ting-Hong
    Yang, Fang-Fang
    Zhu, Yong-Xia
    Li, Ya-Li
    Lei, Qian
    Song, Xue-Jiao
    Xia, Yong
    Xiong, Ying
    Zhang, Li-Dan
    Wang, Ning-Yu
    Zhao, Li-Feng
    Gou, Hong-Feng
    Xie, Yong-Mei
    Yang, Sheng-Yong
    Yu, Luo-Ting
    Yang, Li
    Wei, Yu-Quan
    CELL DEATH & DISEASE, 2017, 8 : e2534 - e2534
  • [33] Inhibition of FGFR signaling by lenvatinib activates tumor interferon gamma signaling pathway and potentiates antitumor activity of anti-PD-1 antibody
    Adachi, Yusuke
    Kamiyama, Hiroshi
    Ichikawa, Kenji
    Ozawa, Yoichi
    Fukushima, Sayo
    Goda, Satoshi
    Yamaguchi, Shogo
    Matsuki, Masahiro
    Miyano, Saori Watanabe
    Yokoi, Akira
    Kato, Yu
    Funahashi, Yasuhiro
    CANCER RESEARCH, 2020, 80 (16)
  • [34] Antitumor activity and immunotherapeutic properties of Flt3-Ligand in a murine breast cancer model
    Chen, KY
    Braun, S
    Lyman, S
    Fan, Y
    Traycoff, CM
    Wiebke, EA
    Gaddy, J
    Sledge, G
    Broxmeyer, HE
    Cornetta, K
    CANCER RESEARCH, 1997, 57 (16) : 3511 - 3516
  • [35] Antitumor activity of Zalypsis® (PM00104) in experimental models of bladder, gastric and liver cancer
    LePage, Doreen J.
    Sasak, Halina
    Guillen, Maria Jose
    Grant, Wendy
    Cuevas, Carmen
    Aviles, Pablo M.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3546S - 3546S
  • [36] ANTITUMOR-ACTIVITY AND MECHANISM OF ACTION OF DIFFERENT ANTIPROGESTINS IN EXPERIMENTAL BREAST-CANCER MODELS
    ELETREBY, MF
    SCHNEIDER, MR
    MICHNA, H
    NISHINO, Y
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 148 - 148
  • [37] Pharmacological Inhibition of β3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity
    Browne, Ashley
    Tookman, Laura A.
    Ingemarsdotter, Carin K.
    Bouwman, Russell D.
    Pirlo, Katrina
    Wang, Yaohe
    McNeish, Iain A.
    Lockley, Michelle
    CANCER RESEARCH, 2015, 75 (14) : 2811 - 2821
  • [38] ANTITUMOR-ACTIVITY AND MECHANISM OF ACTION OF DIFFERENT ANTIPROGESTINS IN EXPERIMENTAL BREAST-CANCER MODELS
    SCHNEIDER, MR
    MICHNA, H
    NISHINO, Y
    ELETREBY, MF
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (06): : 783 - 787
  • [39] Inhibition of the VEGF signaling pathway attenuates tumor-associated macrophage activity in liver cancer
    Okikawa, Shohei
    Morine, Yuji
    Saito, Yu
    Yamada, Shinichiro
    Tokuda, Kazunori
    Teraoku, Hiroki
    Miyazaki, Katsuki
    Yamashita, Shoko
    Ikemoto, Tetsuya
    Imura, Satoru
    Shimada, Mitsuo
    ONCOLOGY REPORTS, 2022, 47 (04)
  • [40] Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway
    Bu, He-Qi
    Luo, Jiang
    Chen, Hui
    Zhang, Jian-Hong
    Li, Hong-Hai
    Guo, Hong-Chun
    Wang, Zhao-Hong
    Lin, Sheng-Zhang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (03) : 949 - 958